Yuehong Hu
Chinese Academy Of Medical Sciences And Peking Union Medical College Fuwai Hospital
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Life-span-dependent transcriptional dynamics of the human heart.
Journal: Science advances
Published: June 17, 2026
Corrigendum "Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction MFSD to repair podocyte damage" [Biomed. & Pharmacother. 174 (2024) 116583].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 10, 2026
Macrophage extracellular traps in autoimmunity: In vivo definition, pathogenic circuits, and therapeutic targeting.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 18, 2025
Mafu Yishen Formula ameliorates membranous nephropathy by promotion of regulatory T cell differentiation: a multi-omics study.
Journal: Chinese medicine
Published: September 19, 2025
Metabolic reprogramming as a therapeutic target for modulating the Th17/Treg balance in autoimmune diseases: a comprehensive review.
Journal: Frontiers in immunology
Published: August 18, 2025
Digital Therapeutics in Cardiovascular Healthcare: A Narrative Review.
Journal: Current cardiology reports
Published: July 23, 2025
Pathological classification of non-ischaemic dilated cardiomyopathy based on deep learning.
Journal: European heart journal. Digital health
Published: May 26, 2025
AAV9-mediated gene supplementation therapy prevents and rescues arrhythmogenic cardiomyopathy in Pnpla2-mutated mice.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 09, 2024
IL-12 family cytokines and autoimmune diseases: A potential therapeutic target?
Journal: Journal of translational autoimmunity
Published: October 20, 2024
Application of Spatial Omics in the Cardiovascular System.
Journal: Research (Washington, D.C.)
Published: July 10, 2024
B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challenges.
Journal: International immunopharmacology
Published: April 29, 2024
Efficacy and safety of Mahuang Fuzi and Shenzhuo Decoction for treatment of primary membranous nephropathy: a multicenter prospective trial.
Journal: Renal failure
Published: March 14, 2024
Last Updated: 09/26/2026